RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 58 filers reported holding RAIN THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,046,178 | -48.6% | 119,700 | -53.0% | 0.01% | -48.1% |
| Q4 2022 | $2,037,024 | +248.8% | 254,628 | +112.7% | 0.03% | +237.5% |
| Q3 2022 | $584,000 | -12.3% | 119,700 | 0.0% | 0.01% | -20.0% |
| Q2 2022 | $666,000 | +9.7% | 119,700 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $607,000 | -60.6% | 119,700 | 0.0% | 0.01% | -54.5% |
| Q4 2021 | $1,542,000 | -13.9% | 119,700 | 0.0% | 0.02% | -24.1% |
| Q3 2021 | $1,791,000 | -3.7% | 119,700 | 0.0% | 0.03% | -17.1% |
| Q2 2021 | $1,860,000 | – | 119,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,560,652 | $7,616,000 | 1.78% |
| Cormorant Asset Management, LP | 2,326,660 | $11,354,000 | 0.79% |
| BVF INC/IL | 3,526,729 | $17,210,000 | 0.71% |
| Perceptive Advisors | 2,483,619 | $12,120,000 | 0.35% |
| Boxer Capital, LLC | 1,175,000 | $5,734,000 | 0.32% |
| UBS OCONNOR LLC | 326,451 | $1,593,000,000 | 0.03% |
| Ergoteles LLC | 65,096 | $318,000 | 0.01% |
| Lumina Fund Management LLC | 6,000 | $29,000 | 0.01% |
| Laurion Capital Management LP | 313,200 | $1,528,000 | 0.01% |
| Woodline Partners LP | 119,700 | $584,000 | 0.01% |